ISDA: 4APP

Deposition Date 2012-04-04

Release Date 2012-06-06

Last Version Date 2024-10-23

Entry Detail

PDB ID:

4APP

Keywords:

TRANSFERASE

Title:

Crystal Structure of the Human p21-Activated Kinase 4 in Complex with (S)-N-(5-(3-benzyl-1-methylpiperazine-4-carbonyl)-6,6-dimethyl-1,4,5, 6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-phenoxybenzamide

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.20 Å

R-Value Free:

0.22

R-Value Work:

0.18

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:SERINE/THREONINE-PROTEIN KINASE PAK 4
Gene (Uniprot):PAK4
Chain IDs:A
Chain Length:296
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:O96013 Pfam ID:PF00069 EC:2.7.11.1

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
SEP	A	SER	PHOSPHOSERINE

Ligand Molecules

GOL

N53

Primary Citation

Discovery of Pyrroloaminopyrazoles as Novel Pak Inhibitors.

Guo, C, Mcalpine, I, Zhang, J, Knighton, D.D, Kephart, S, Johnson, M.C, Li, H, Bouzida, D, Yang, A, Dong, L, Marakovits, J, Tikhe, J, Richardson, P, Guo, L.C, Kania, R, Edwards, M.P, Kraynov, E, Christensen, J, Piraino, J, Lee, J, Dagostino, E, Del-Carmen, C, Deng, Y.L, Smeal, T, Murray, B.W.Show

J.Med.Chem. 55 4728 ? (2012)

PMID: 22554206 DOI: 10.1021/JM300204J

Abstact

The P21-activated kinases (PAK) are emerging antitumor therapeutic targets. In this paper, we describe the discovery of potent PAK inhibitors guided by structure-based drug design. In addition, the efflux of the pyrrolopyrazole series was effectively reduced by applying multiple medicinal chemistry strategies, leading to a series of PAK inhibitors that are orally active in inhibiting tumor growth in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form